Trontinemab, an experimental drug developed by Roche, has sparked excitement in large trials for slowing Alzheimer’s faster and safer than anything before.
Leqembi, the first Alzheimer’s-modifying drug, is a giant step forward—but how many people are getting it, and what does it really cost the average American? We dig into the numbers, the barriers, and the path forward.
Does pain relief risk cognitive cost? A major new study of almost 200,000 people says yes—and the price may be higher than we thought.
Why Do Babies Have More Alzheimer’s Protein Than Adults? A Surprising Clue to Future Treatments
Diagnosing the right dementia type often takes months. It can make a big difference. Mayo Clinic’s AI tool identifies 9 dementia types, including Alzheimer’s, with one scan — a transformative advance in early, accurate diagnosis.
Bill Gates says, “I am blown away by how much we have learned about Alzheimer’s disease over the last couple years.” See his compelling video and insight-filled blog post.
Adopting the MIND diet—even later in life—is linked with reduced dementia risk
See one of the largest and most comprehensive studies identifying where dementia occurs most often.
Sleep aid lemborexant (better known by its brand name Dayvigo) showed 40% more hippocampal brain volume than other drugs.
Lecanemab is today’s #1 Alzheimer’s antibody. (Brand name: Leqembi) Washington University researchers found Lecanemab’s adverse events to be rare and manageable in very mild or mild Alzheimer’s.
If you’ve found a way to make Alzheimer’s care easier or more compassionate, Maude’s Awards want to hear about it.
Denise Medved is the founder and creator of a program that takes Alzheimer’s patients through vigorous, spirited exercise routines. She calls her program, “Ageless Grace”.
Learn about ‘personalized music for dementia’ and its powerful effect on Alzheimer’s. See the Director of the hit film, ‘Alive Inside’, on the dementia-impact of music.
In a study on health & cynicism, people were asked how much they agree with statements such as, “I think most people would lie to get ahead,” and “It is safer to trust nobody”. The clear connection between their answers and their risk of dementia may startle you.
Lewis Hornby had a problem: his grandmother with dementia wasn’t drinking enough, causing her to get severely dehydrated.
Dr. Richard Taylor has Alzheimer’s and the right attitude!
Swedish researchers find that cholinesterase inhibitors provide cognitive benefits and reduce mortality for up to five years after an Alzheimer’s diagnosis. One medication significantly reduced the risk of developing severe dementia.
No spam, only news and updates.
